• 1. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

Professional Introduction to Compound with CAS No. 1261921-61-2 and Product Name: 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol

Compound with the CAS number 1261921-61-2 and the product name 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol represents a significant advancement in the field of pharmaceutical chemistry. This compound, characterized by its unique structural and functional properties, has garnered considerable attention in recent years due to its potential applications in medicinal chemistry and drug development. The N,N-Dimethylaminocarbonyl moiety in its molecular structure plays a crucial role in modulating its reactivity and biological activity, making it a valuable candidate for further exploration.

The phenylphenol backbone of this compound contributes to its stability and solubility characteristics, which are essential factors in formulating effective pharmaceutical agents. Current research indicates that derivatives of this compound exhibit promising properties as intermediates in the synthesis of bioactive molecules. Specifically, studies have demonstrated that modifications to the N,N-Dimethylaminocarbonyl group can significantly alter the pharmacokinetic profile of the compound, enhancing its bioavailability and therapeutic efficacy.

In the realm of medicinal chemistry, the synthesis and optimization of 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol have been influenced by advancements in catalytic methods and green chemistry principles. Recent publications highlight the use of transition metal-catalyzed cross-coupling reactions to introduce functional groups at specific positions on the aromatic ring, thereby tailoring the compound's biological activity. These methodologies not only improve yield but also reduce environmental impact, aligning with global trends toward sustainable chemical practices.

One of the most intriguing aspects of 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol is its potential as a scaffold for developing novel therapeutic agents. Researchers have explored its interactions with various biological targets, including enzymes and receptors involved in metabolic pathways. Preliminary data suggest that this compound exhibits inhibitory effects on certain enzymes associated with inflammation and oxidative stress, which are key mechanisms in chronic diseases such as cancer and neurodegenerative disorders. These findings have opened new avenues for investigating its role in disease prevention and treatment.

The structural flexibility of 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol allows for diverse chemical modifications, enabling the creation of a library of analogs with tailored properties. Techniques such as computational modeling and high-throughput screening have been employed to identify lead compounds with enhanced potency and selectivity. These approaches leverage artificial intelligence and machine learning algorithms to predict molecular behavior, accelerating the drug discovery process.

Furthermore, the pharmacological profile of 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol has been studied in preclinical models to assess its safety and efficacy. Animal studies have shown that this compound exhibits low toxicity at therapeutic doses while maintaining significant biological activity. The absence of notable side effects makes it an attractive candidate for further development into a clinical candidate. However, additional research is required to fully understand its long-term effects and optimal dosing regimens.

The role of 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol in drug development is also influenced by regulatory considerations. Compliance with international standards ensures that pharmaceutical products derived from this compound meet stringent quality control measures. Regulatory bodies such as the FDA and EMA have provided guidelines for assessing the safety and efficacy of new chemical entities, which include comprehensive toxicological studies and clinical trials.

Future research directions for 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol include exploring its potential applications in personalized medicine. By integrating genetic data with pharmacological insights, researchers aim to develop targeted therapies that address individual patient needs. This approach could enhance treatment outcomes while minimizing adverse reactions, representing a significant step forward in precision healthcare.

The synthesis of 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol also benefits from innovations in synthetic methodologies. Continuous flow chemistry has emerged as a powerful tool for producing complex molecules efficiently and sustainably. This technology allows for precise control over reaction conditions, reducing waste generation and improving scalability. Such advancements are critical for transitioning promising candidates like this compound into viable pharmaceutical products.

In conclusion, 2-4-(N,N-Dimethylaminocarbonyl)phenylphenol, identified by CAS No. 1261921-61-2, represents a compelling example of how structural innovation can drive progress in pharmaceutical chemistry. Its unique properties make it a versatile scaffold for developing novel therapeutic agents, with applications spanning multiple disease areas. As research continues to uncover new possibilities for this compound, it holds promise for improving patient care through innovative drug solutions.

• 1778-08-1(2-Hydroxy-N,N-dimethylbenzamide)
• 1261896-44-9(4-3-(N,N-Dimethylaminocarbonyl)phenylphenol)
• 1261984-36-4(2-3-(N,N-Dimethylaminocarbonyl)phenylphenol)
• 1261943-43-4(2-3-(N-Methylaminocarbonyl)phenylphenol)
• 1093118-91-2(4-(3-formyl-4-hydroxyphenyl)-n,n-dimethylbenzamide)
• 1261947-55-0(3-(3-hydroxy-4-methylphenyl)-n-methylbenzamide)
• 1093119-81-3(3-(3-formyl-4-hydroxyphenyl)-n,n-dimethylbenzamide)
• 1261898-17-2(3-(3-formyl-4-hydroxyphenyl)-n-methylbenzamide)
• 1159944-09-8(4-4-(N,N-Dimethylaminocarbonyl)phenylphenol)
• 63992-45-0([1,1'-Biphenyl]-3-carboxamide,N,N-diethyl-2-hydroxy-)